Global and China Hemodialysis Industry Report, 2013-2016
  • May 2014
  • Hard Copy
  • USD $2,550
  • Pages:109
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: HK043
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,700
  • Hard Copy + Single User License
  • USD $2,750

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure.

In 2013, the global number of patients receiving dialysis continued to grow to 2.519 million. The new patients mainly come from Asia Pacific region (excluding Japan), whereas for Europe, America, Japan and other mature markets, since these countries have a higher proportion of patients with advanced renal failure receiving treatment, so they have a slower growth in the number of patients receiving dialysis. For example, in 2013, the number of patients receiving dialysis in Asia-Pacific region grew by 17.0% YoY; while in Japan, EU and US, the number of patients receiving dialysis grew by only 2%-4% YoY.

The global hemodialysis market can be divided into two parts: hemodialysis service and hemodialysis equipment, of which the scale of hemodialysis service market is larger, accounting for about 85% of the overall market.

1 Hemodialysis Service Market

Global hemodialysis service market has great regional differences: in Europe and Asia Pacific, public institutions dominate, however, in North America, private-company-operated institutions and in Latin America, private clinics are the main forms. Currently, global companies providing hemodialysis service mainly include Fresenius Medical Care, DaVita, etc. The number of patients receiving hemodialysis in these two companies in 2013 came to nearly 340,000.

Dialysis services in China are mainly provided by all levels of hospitals, mainly due to that currently the national health insurance reimbursement ratio is relatively low and the affordability of patients is not high, resulting in lower proportion of patients with end-stage renal disease undergoing dialysis treatment, which was only about 12% in 2013. In 2013 the number of Chinese patients with renal failure undergoing dialysis treatment (mainly hemodialysis treatment) was approximately 250,000, and number of patients undergoing peritoneal dialysis was less than 30,000. But with the gradual expansion of China's health insurance coverage at all levels, the proportion of patients with end stage renal disease undergoing treatment will rise sharply and the market prospects will be very promising.

2 Dialysis Equipment Market

The global hemodialysis equipment market is relatively concentrated, mainly dominated by European, American and Japanese companies. The first-tier brands are American and European brands, including Germany-based Fresenius and Braun, U.S.-based Baxter and so on; the second-tier brands mainly are Japanese brands, including NIKKISO, Nipro, Toray and so on. In 2013, market share of Fresenius and Baxter in the global dialysis equipment market reached 34% and 30% respectively.

Local Chinese hemodialysis equipment has poor competitiveness and low market share. In 2013, China's hemodialysis equipment import dependency rate was about 70%. Chinese manufacturers in the field of dialysis include: hemodialysis machine manufacturers like Jihua Medical Apparatus and Instruments Co., Ltd, Guangdong Biolight Meditech Co., Ltd and Chongqing Shanwaishan Science & Technology Co., Ltd; dialyzer manufacturers include Shandong Weigao Group and Jiangsu Lengthen Life Science and Technology Co., Ltd; peritoneal dialysis solution manufacturers include Huaren Pharmaceutical Co., Ltd and Sichuan Kelun Pharmaceutical Co., Ltd.


The "Global and China Hemodialysis Industry Report, 2013-2016" published by ResearchInChina includes the following main contents:
20120114.gifGlobal hemodialysis population and distribution, etc.;
20120114.gifStatus quo, competition pattern and development trend of the global hemodialysis equipment and service markets;
20120114.gifMarket scale, competition pattern, import & export and development forecasting, etc of China hemodialysis industry;
20120114.gifStatus quo and competition pattern of global and China hemodialysis equipment market segments;
20120114.gifOperational analysis, hemodialysis business analysis and development forecasting of 16 global and Chinese enterprises in the hemodialysis industry.

1 Hemodialysis Industry Overview
1.1 Definition
1.2 Hemodialysis Equipment
1.3 Hemodialysis Service
1.3.1 In-Center Hemodialysis
1.3.2 Home Hemodialysis
1.4 Industry Chain

2 Global Hemodialysis Market
2.1 Dialysis Population
2.2 Overall Market Situation
2.3 Hemodialysis Equipment Market
2.4 Hemodialysis Service Market

3 China Hemodialysis Market
3.1 Status Quo
3.2 Policy Environment
3.3 Competition Pattern
3.4 Market Scale

4 China Hemodialysis Equipment Import and Export 
4.1 Import
4.2 Export

5 Hemodialysis Market Segments
5.1 Hemodialysis Machine
5.2 Peritoneal Dialysis
5.3 Dialyzer
5.4 Dialysis Loop Tube
5.5 Dialysis Concentrate
5.6 Hemodialysis Machine for Home Use
5.7 Hemodialysis Membrane

6 Major Foreign Manufacturers
6.1 Fresenius Medical Care
6.1.1 Profile
6.1.2 Operation
6.1.3 Dialysis Product Business
6.1.4 Dialysis Service Business
6.1.5 Number of Patients Receiving Dialysis
6.1.6 Development Situation
6.1.7 Business in China
6.2.1 Profile
6.2.2 Operation
6.2.3 Hemodialysis Business
6.2.4 Business in China
6.3 Baxter
6.3.1 Profile
6.3.2 Operation
6.3.3 Hemodialysis Business
6.3.4 Acquisition of Gambro AB
6.3.5 Operating Conditions in China
6.4 Asahi Kasei
6.4.1 Profile
6.4.2 Operation
6.4.3 Operating Conditions of the Health Care Division
6.4.4 Business in China
6.5 Nipro
6.5.1 Profile
6.5.2 Operation
6.5.3 Hemodialysis Business
6.5.4 Business in China
6.6 B. Braun Melsungen AG
6.6.1 Profile
6.6.2 Operation
6.6.3 Hemodialysis Business
6.6.4 Business in China
6.7 Nxstage
6.7.1 Profile
6.7.2 Operation
6.7.3 Portable Hemodialysis Machine Business
6.7.4 Hemodialysis Consumables Business

7 Major Manufacturers in China
7.1 Weigao Group
7.1.1 Profile
7.1.2 Operation
7.1.3 Revenue Structure
7.1.4 R & D
7.1.5 Hemodialysis Business
7.1.6 Development Prospects and Forecasting
7.2 Huaren Pharmaceutical
7.2.1 Profile
7.2.2 Operation
7.2.3 Hemodialysis Business
7.3 Guangdong Biolight Meditech
7.3.1 Profile
7.3.2 Operation
7.3.3 Revenue Structure
7.3.4 Gross Margin
7.3.5 R & D
7.3.6 Clients
7.3.7 Hemodialysis Business
7.3.8 Forecasting and Outlook
7.4 Kelun Pharmaceutical
7.4.1 Profile
7.4.2 Operation
7.4.3 Hemodialysis business
7.5 Jihua Medical Apparatus and Instruments
7.5.1 Profile
7.5.2 Hemodialysis Business
7.6 Bain Medical Equipment
7.6.1 Profile
7.6.2 Operation
7.6.3 Hemodialysis Business
7.7 Beijing United Bio-Tech
7.7.1 Profile
7.7.2 Operation
7.8 Jiangsu Lengthen Life Science and Technology
7.8.1 Profile
7.8.2 Operation
7.8.3 Hemodialysis Business
7.9 Guangzhou Koncen BioScience
7.9.1 Profile
7.9.2 Operation

8 Summary and Forecasting
8.1 Summary
8.2 Development Forecasting
8.2.1 Increasing Hemodialysis Population 
8.2.2 Steadily Increasing Proportion of Dialysis Treatment 
8.2.3 Market Size Forecasting
Pros and Cons of In-Center Hemodialysis
Pros and Cons of Home Hemodialysis
Hemodialysis Industry Chain
Global Number of Nephritic Patients Receiving Dialysis, 1990-2020E
Global Number of Patients Receiving Dialysis Treatment, 2011-2013
Patients Receiving Dialysis Treatment Worldwide by Region, 2011-2013 
Patients Receiving Dialysis Treatment Worldwide by Country, 2011-2013 
Competition Structure of Global Dialysis Equipment Market, 2013
Competition Structure of Global Hemodialysis Machine Market, 2013
Competition Structure of Global Peritoneal Dialysis Equipment Market, 2013
Global Number of Patients with Advanced Renal Failure by Treatment Method, 2011-2013 
Proportions of Global Number of Patients with Advanced Renal Failure (by Treatment Method), 2011-2013
Service Forms of Global Dialysis Industry (by Region), 2013
Service Forms of Major Countries and Regions in Global Dialysis Industry, 2013
Number of Patients Receiving Dialysis at the World's Top Five Dialysis Service Providers, 2013
Number of Patients Receiving Dialysis at the World’s Leading Hemodialysis Service Providers (by Region), 2013
Amount of China’s Hemodialysis Equipment Trade Deficit, 2008-2013
Products of China’s Major Hemodialysis Machine Manufacturers Holding Medical Device Registration Certificate, 2013  
Geographical Distribution of Chinese Dialysis Equipment Manufacturers, 2013
China's Dialysis Market Size, 2013
China's Hemodialysis Equipment Import Value and Growth Rate, 2009-2013
China's Hemodialysis Equipment Import Volume and Growth Rate, 2009-2013
China's Hemodialysis Equipment Import Source Structure (by Import Value), 2011-2013
Comparison by Average Unit Price of China’s Hemodialysis Equipment Imports (by Country), 2011-2013
China’s Hemodialysis Equipment Import Value Structure by Province/City, 2011-2013
China's Hemodialysis Equipment Export Value and Growth Rate, 2009-2013
China's Hemodialysis Equipment Export Destination Structure (by Export Value), 2013
China's Hemodialysis Equipment Export Value Structure by Province/City, 2013
Introduction of Some Small Hemodialysis Machines 
Five Branches of Fresenius Group 
Net Revenue and Net Income of Fresenius Medical Care, 2009-2013
Net Revenue Structure of Fresenius Medical Care (by Product), 2011-2013
Net Revenue Structure of Fresenius Medical Care (by Region), 2011-2013
Net Revenue and Growth Rate of Dialysis Products of Fresenius Medical Care, 2009-2013
Net Revenue Structure of Dialysis Products of Fresenius Medical Care (by Region), 2011-2013
Revenue and Growth Rate of Dialysis Service of Fresenius Medical Care, 2009-2013
Net Revenue Structure of Dialysis Service of Fresenius Medical Care (by Region), 2011-2013
Number of Patients Receiving Dialysis Treatment at Fresenius Medical Care and YoY Growth Thereof, 2009-2013
Proportion of Patients Receiving Dialysis Treatment at Fresenius Medical Care (by Region), 2011-2013
Market Share of Fresenius Medical Care in the World's Major Markets (by Number of Patients Receiving Dialysis), 2013
Production Plants and Main Products of Fresenius Medical Care, 2013
Operation of Fresenius Medical Care's Subsidiaries in China, 2013
Main Business of NIKKISO by Division, 2013
Net Sales and Net Income of NIKKISO, FY2008-FY2012
Net Sales Structure of NIKKISO (by Division), FY2012
Net Sales Structure of NIKKISO (by Region), FY2012
Hemodialysis-Related Factories of NIKKISO, 2013
Net Sales and YoY Growth of Medical Division of NIKKISO, FY2008-FY2012
Main Business and Products of Baxter
Net Sales and Net Income of Baxter, 2009-2013
Net Sales Structure of Baxter (by Division), 2011-2013
Net Sales Structure of Baxter (by Region), 2011-2013
Net Sales Structure of Medical Products Division of Baxter (by Product), 2011-2013
Net Sales and YoY Growth of Renal Business of Baxter, 2009-2013
Net Sales Structure of Renal Business of Baxter (by Region), 2010-2012
Net Sales and EBITDA of Gambro AB, 2008-2012
Main Business of Baxter’s Factories in China, 2012
Main Business of Nine Core Operating Companies of Asahi Kasei
Net Sales and Net Income of Asahi Kasei, FY2008-FY2012 
Net Sales Structure of Asahi Kasei (by Division), FY2010-FY2012
Net Sales and Operating Income of Health Care Division of Asahi Kasei, FY2008-FY2012
Major Affiliates of Asahi Kasei Medical
Operating Revenue and Operating Income of Asahi Kasei Medical (Hangzhou), 2007-2009
Three Major Business Segments and Specific Business of Nipro
Net Sales and Net Income of Nipro, FY2008-FY2012
Sales Structure of Nipro (by Business), FY2012
Sales Structure of Nipro (by Region), FY2012
Net Sales and Operating Income of Medical-Care-Related Business of Nipro, FY2008-FY2012 
Net Sales and Operating Income of Pharmaceutical-Related Business of Nipro, FY2008-FY2012
Business of Nipro’s Subsidiaries in China
Hemodialysis Products of Nipro Trading (Shanghai) 
Operating Revenue and Total Profit of Nipro Trading (Shanghai), 2007-2009
Main Business of Four Divisions of B.Braun 
Sales and EBITDA of B.Braun, 2009-2013
Sales Structure of B.Braun (by Division), 2011-2013
Sales Structure of B.Braun (by Region), 2011-2013
Sales Structure of B.Braun (by Product and Service), 2011-2013
Sales and YoY Growth of B.Braun Avitum, 2009-2013
Main Business of B.Braun’s Subsidiaries in Mainland China, 2013
Sales of B.Braun Avitum (Shanghai) Trading Company Limited, 2009-2013
Main Business Divisions and Business of Nxstage 
Total Revenue and Gross Profit of Nxstage, 2009-2013 
Revenue Structure of Nxstage (by Division), 2011-2013
Revenue and Gross Profit of Portable Hemodialysis Machine Division of Nxstage, 2009-2013
Revenue Structure of Portable Hemodialysis Machine Division of Nxstage (by Business), 2011-2013
Revenue and Gross Profit of Hemodialysis Consumables of Nxstage, 2008-2012
Product Line of Weigao Group
Revenue and Net Income of Weigao Group, 2009-2013
Revenue Breakdown of Weigao Group (by Product), 2011-2013
Output of Main Products of Weigao Group, 2011-2013
Revenue Structure of Weigao Group (by Product), 2011-2013
Revenue Breakdown of Weigao Group (by Region), 2011-2013
Revenue Structure of Weigao Group (by Region), 2011-2013
R&D Costs and % of Total Revenue of Weigao Group, 2010-2012
Hemodialysis-Related Subsidiaries of Weigao Group, 2013
Revenue and Net Income of Weigao Group, 2012-2016E
Revenue and Net Income of Huaren Pharmaceutical, 2009-2013
Revenue and Net Income of Guangdong Biolight Meditech, 2009-2013
Revenue Breakdown of Guangdong Biolight Meditech (by Product), 2011-2013
Revenue Structure of Guangdong Biolight Meditech (by Product), 2011-2013
Revenue Breakdown of Guangdong Biolight Meditech (by Region), 2011-2013
Revenue Structure of Guangdong Biolight Meditech (by Region), 2011-2013
Gross Margin of Main Products of Guangdong Biolight Meditech, 2011-2013
R&D Costs and % of Total Revenue of Guangdong Biolight Meditech, 2011-2013
Guangdong Biolight Meditech’s Revenue from Top 5 Clients and % of Total Revenue, 2011-2013
Name List, Revenue Contribution and % of Guangdong Biolight Meditech's Top 5 Clients, 2013
Hemodialysis-Related Subsidiaries of Guangdong Biolight Meditech, 2013
Output and Sales Volume of Dialysis Solution/Powder of Guangdong Biolight Meditech, 2012-2013
Revenue and Net Income of Guangdong Biolight Meditech, 2012-2016E
Revenue and Net Income of Kelun Pharmaceutical, 2009-2013
Revenue and Net Income of Chengdu Qingshan Likang Pharmaceutical, 2012-2013
Hemodialysis Series Products of Jihua Medical Apparatus and Instruments
Operating Revenue, Total Profit and Gross Margin of Bain Medical Equipment, 2008-2009
Operating Revenue, Total Profit and Gross Margin of Beijing United Bio-Tech, 2007-2009
Operating Revenue, Total Profit and Gross Margin of Jiangsu Lengthen Life Science and Technology, 2007-2009
Shareholding Structure of Guangzhou Koncen Bioscience as of 2013
Product Line of Guangzhou Koncen Bioscience
Key Financial Indicators of Guangzhou Koncen Bioscience, 2012-2013
Operation Comparison between Global and Chinese Hemodialysis Enterprises, 2013
Positive Correlation between the Number of ESRD Patients per Million Population and GDP Per Capita
China Hemodialysis Market Size, 2013-2016E

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号